Dr. Kimberly Negrin plays a leadership role for Charles River’s cellular products business overseeing and supporting clients as they mature through research, clinical, and commercial development of novel engineered and manufactured cell therapy products and applications. Kimberly is responsible for directing strategic planning efforts and leading cross-functional strategic projects across Charles River’s integrated CGT portfolio. She previously worked at Agilent Technologies and Seahorse Bioscience.
She completed her doctoral training at UMass Medical School in the Department of Molecular Medicine, where she earned her PhD in biomedical science. She is active in the Boston-area scientific community as a member of several local women’s entrepreneurial and technologically focused groups. Dr. Negrin is currently the President of the Association of Women in Science, Central Massachusetts chapter.